Amaurosis in patients with giant cell arteritis: Treatment with anti-tumour necrosis factor-α; [2]

Internal Medicine Journal

Volumn 37, Issue 4, 2007, Pages 280-281

  Torrente, S V ^a   Guerri R C ^a   Perez Garcia C ^a   Benito, P ^a   Carbonell, J ^a  

^a HOSPITAL DEL MAR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DEFLAZACORT; ETANERCEPT; INFLIXIMAB; PREDNISONE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

AGED; BLINDNESS; CASE REPORT; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DOSE RESPONSE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GIANT CELL ARTERITIS; HUMAN; HYPOTHYROIDISM; LETTER; OPTIC NEURITIS; PRIORITY JOURNAL; THERAPY EFFECT;

AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; BLINDNESS; FEMALE; HUMANS; OPTIC NEUROPATHY, ISCHEMIC; TEMPORAL ARTERITIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33947360684     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2006.01299.x     Document Type: Letter

References (7)

1. Tan AL, Holdsworth J, Pease C, Emery P, McGonagle D. Successful treatment of resistant giant cell arteritis with etanercept. Ann Rheum Dis 2003; 62: 373-4.
2. Airó P, Antonioli CM, Vianelli M, Tonati P. Anti-tumour necrosis factor treatment with infliximab in a case of giant cell arteritis resistant to steroid and immunosuppressive drugs. Rheumatology 2002; 41: 347-9.
3. Cantini F, Niccoli L, Salvarani C, Padula A, Olivieri I. Treatment of longstanding active giant cell arteritis with infliximab: report of four cases. Arthritis Rheum 2001; 44: 2933-5.
4. Field M, Cook A, Gallagher G. Immuno-localisation of tumor necrosis factor and its receptors in temporal arteritis. Rheumatol Int 1997; 17: 113-18.
5. Wagner AD, Wittkop U, Prahst A, Schmidt WA, Gromnica-Ihle E, Vorpahl K et al. Dendritic cells co-localize with activated CD4+ T cells in giant cell arteritis. Clin Exp Rheumatol 2003; 21: 185-92.
6. Blain H, Abdelmouttaleb I, Belmin J, Blain A, Floquet J, Gueant JL et al. Arterial wall production of cytokines in giant cell arteritis: results of a pilot study using human temporal artery cultures. J Gerontol A Biol Sci Med Sci 2002; 57: M241-5.
7. Gonzalez-Gay MA, Blanco R, Rodriguez-Valverde V, Martinez-Taboada VM, Delgado-Rodriguez M, Figueroa M et al. Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment. Arthritis Rheum 1998; 41: 1497-504.